Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on May 15, 2025
Ancient Biblical Remedies Under Review: Ancient Lost Remedies Revived with Hidden Healing Secret Remedies of the Scriptures
GlobeNewswire
·
May 15, 2025
New York, May 15, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: How The Encyclopedia of Natural Remedies by 365 Daily Health unveils ancient biblical remedies drawn from scripture Why chronic health issues like inflammation, fatigue, and …
FuturHealth Under Review: Best GLP-1 Semaglutide Medication Prescription for Weight Loss with No Insurance
GlobeNewswire
·
May 15, 2025
San Diego, May 15, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why millions of Americans are turning to GLP-1 semaglutide prescriptions for weight loss without insurance The top pain points consumers face in traditional weight loss and …
HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results
GlobeNewswire
·
May 15, 2025
MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …
Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
GlobeNewswire
·
May 15, 2025
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive. …
BioSyent Releases Financial Results for First Quarter 2025
GlobeNewswire
·
May 15, 2025
MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2025. Key highlights include: (CAD) Q1 2025 % Change vs. Q1 2024 Trailing …
BioSyent Declares Second Quarter 2025 Dividend
GlobeNewswire
·
May 15, 2025
MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on …
Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 15, 2025
Conference call begins at 10:00 a.m. Eastern time on Friday, May 16, 2025 WOBURN, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic …
Shuttle Pharma Provides Corporate Update
GlobeNewswire
·
May 15, 2025
GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation
GlobeNewswire
·
May 15, 2025
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
GlobeNewswire
·
May 15, 2025
Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a …
Combined General Meeting of June 11, 2025
GlobeNewswire
·
May 15, 2025
Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a …
Assemblée Générale Mixte du 11 juin 2025
GlobeNewswire
·
May 15, 2025
Châtillon, France, le 15 mai 2025 Assemblée Générale Mixte du 11 juin 2025 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market …
Hapbee Technologies Teams Up with Liberty Alliance to Deliver Wearable Sleep and Performance Technology to the Defense Sector; Updates Status of Audited Financial Statements
GlobeNewswire
·
May 15, 2025
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF), a leading provider of wearable wellness technology, is proud to announce it has teamed up with Liberty Alliance, a veteran-owned business ( …
Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 15, 2025
GARDNER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an …
Globus Medical Announces $500 Million Share Repurchase Program
GlobeNewswire
·
May 15, 2025
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company’s …
SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for …
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
GlobeNewswire
·
May 15, 2025
Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its new marketing and distribution model Management to Host …
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
GlobeNewswire
·
May 15, 2025
ROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and reported financial …
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025
GlobeNewswire
·
May 15, 2025
BASEL, Switzerland and LONDON and NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 29, 2025, to report its financial results for the …
Range Impact Reports 1Q 2025 Financial Results
GlobeNewswire
·
May 15, 2025
Cleveland, Ohio, May 15, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reports its results for the …